Publications by authors named "Marie Anne Iannone"

is a leading cause of community-acquired pneumonia. Intercellular adhesion molecule-1 (ICAM-1) is an adhesion molecule that is highly expressed on the pulmonary capillary endothelium, alveolar epithelium, and other cell types within the lung. ICAM-1 plays important roles in leukocyte adhesion, migration, and motility.

View Article and Find Full Text PDF

Curative strategies for human immunodeficiency virus (HIV-1) infection are hindered by incomplete characterization of the latent reservoir and limited enhancement of anti-HIV immune responses. In this study, we identified a novel dual role for peripheral and tissue-resident Vδ1 T cells within the gastrointestinal mucosa of virally suppressed people with HIV. Phenotypic analyses identified an increased frequency of highly differentiated, cytotoxic effector Vδ1 T cells that exerted potent inhibition of HIV-1 replication coinciding with direct increases in cytolytic function.

View Article and Find Full Text PDF

Antiretroviral therapy (ART) is not curative due to the existence of cellular reservoirs of latent HIV-1 that persist during therapy. Current research efforts to cure HIV-1 infection include "shock and kill" strategies to disrupt latency using small molecules or latency-reversing agents (LRAs) to induce expression of HIV-1 enabling cytotoxic immune cells to eliminate infected cells. The modest success of current LRAs urges the field to identify novel drugs with increased clinical efficacy.

View Article and Find Full Text PDF
Article Synopsis
  • Antiretroviral therapy (ART) does not cure HIV-1 due to persistent latent reservoirs; current research focuses on "shock and kill" strategies to reactivate the virus for immune elimination.
  • Aminobisphosphonates (N-BPs), commonly used for bone diseases, have been shown in recent studies to effectively reactivate latent HIV-1, achieving results similar to established T cell activators.
  • Preliminary findings suggest that N-BPs activate immune responses and induce HIV-1 expression, warranting further research in controlled clinical trials, potentially alongside therapeutic vaccination.
View Article and Find Full Text PDF